February 19, 2017

Health Care, Medicare, Affordable Care Act, HIPAA Legal News

Fastest growing and most heavily regulated, the health care industry is one of the most legally complex industries for companies to navigate. The National Law Review is a free resource of health care legal articles addressing regulatory developments, contractual obligations and disputes for both profit and not-for-profit health care organizations. We cover the latest regulatory actions by the U.S. Department of Health and Human Services (“HHS”), Office for Civil Rights (“OCR”), Centers for Medicare & Medicaid Services (“CMS”) and Food and Drug Administration (“FDA”). Emerging regulatory issues and enforcement topics include Affordable Care Act (“Obamacare”) compliance, home health and managed care providers, hospice care, drug pricing, Medicare reimbursement and access, and antitrust scrutiny of healthcare organizations.

Rapidly developing technologies in health care force companies to deal with a host of new issues such as Ransomware, compliance with the new 21st Century Cures Act, Health Insurance Portability and Accountability Act (“HIPAA”), Genetic Information Nondiscrimination Act (“GINA”), telemedicine, and telehealth standards. We also provide the latest legal news on communications and privacy issues pertinent to the health care field regarding medical devices, wellness devices, electronic health records (“EHR”), and life sciences technologies.

Date Title Organization
17
Feb
CDC Issues New Guidance For Use of EPA-Registered Disinfectants in Environmental Control of Candida auris for U.S. Healthcare Facilities Bergeson & Campbell, P.C.
17
Feb
FDA Hardens Its Stance on Intended Use and Off-Label Use and Industry Responds Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
17
Feb
The Future of the Affordable Care Act Week 6: Focus on the Individual Health Insurance Market Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
16
Feb
Fourth Circuit Punts at Rare Opportunity to Rule on Statistical Sampling Sheppard, Mullin, Richter & Hampton LLP
15
Feb
Reference-Based Pricing: Case Study & Discussion [VIDEO] K&L Gates
15
Feb
CMS’s Draft 2018 Call Letter: Minor Updates, but Largely Continuation of Current Policies Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
14
Feb
Will Ninth Circuit Verdict Encourage Counsel To Become Healthcare Relators? Squire Patton Boggs (US) LLP
14
Feb
Tenth Circuit Court Agrees Difference Of Opinion On Medical Necessity Is Insufficient to Show Falsity Under False Claims Act Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
14
Feb
CMS Nominee Seema Verma Visits Senate Finance Squire Patton Boggs (US) LLP
13
Feb
Enforcement Status of ACA Section 1557 Regulations Morgan, Lewis & Bockius LLP
13
Feb
Affordable Care Act Replacement Bills Encounter Beltway Traffic Jones Walker LLP
13
Feb
Minimal Fines Little Incentive for Facilities to Improve Patient Care Rosenfeld Injury Lawyers
11
Feb
St. Jude Cybersecurity Vulnerability Extended to Provider-Owned Devices Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
11
Feb
Week Ahead in European Parliament – February 10, 2017: Public Health and Food Safety; CETA; Committee on Legal Affairs Covington & Burling LLP
10
Feb
Clinical Research (R)evolution – Updating the “Common Rule” for the Modern Era Drinker Biddle & Reath LLP
10
Feb
Health Systems Governance: Board Refreshment McDermott Will & Emery
10
Feb
340B Drug Pricing Program Omnibus Guidance Withdrawn Godfrey & Kahn S.C.
10
Feb
Effective Use of Health System Board Committees McDermott Will & Emery
10
Feb
Closer Scrutiny of Nonprofit Health Systems Board Conflicts McDermott Will & Emery
10
Feb
The Number One Fiduciary Duty Issue of 2017: Uncertainty McDermott Will & Emery

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS